Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.

The Journal of rheumatology - 1 Jun 2016

Kim Kwangwoo, Bang So-Young, Joo Young Bin, Kim Taehyeung, Lee Hye-Soon, Kang Changwon, Bae Sang-Cheol

Abstract excerpt

OBJECTIVE: Cyclophosphamide (CYC) is an immunosuppressant drug widely used to treat various diseases including lupus nephritis, but its efficacy highly varies from individual to individual. This pharmacogenomics association study searched for genetic variations associated with CYC efficacy. METHODS: Genome-wide association scan was performed for 109 Korean patients with systemic lupus erythematosus with lupus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intravenous
Share to Cyclophosphamide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Lupus Nephritis

Share to Pharmacogenetics

Share to Receptors, Fc

Share to Receptors, IgG

Share to Receptors, Immunologic

Source

Identifiers

PMID: 26980576
DOI: 10.3899/jrheum.150665

Genes

FCRLA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Response to Intravenous Cyclophosphamide Treatment for Lupus Nephritis Associated with Polymorphisms in the FCGR2B-FCRLA Locus.PMID 26980576Read ↗

Genetic Polymorphisms Associated with Cyclophosphamide Outcome and Risk of Toxicity in Patients with Lupus Nephritis.Semantic proximity Read ↗

FCGR2B and FCRLB gene polymorphisms associated with IgA nephropathy.Semantic proximity Read ↗

HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.Semantic proximity Read ↗

NR3C1 Glucocorticoid Receptor Gene Polymorphisms Are Associated with Membranous and IgA Nephropathies.Semantic proximity Read ↗

Polymorphisms in FCN genes and their influence on systemic lupus erythematosus susceptibility: a report from Western India.Semantic proximity Read ↗

Exploring the Correlation Between Genotypes of Drug-Metabolizing Enzymes and the Therapeutic Efficacy and Adverse Reactions of Cyclophosphamide in Childhood-Onset Lupus Nephritis: A Chinese Cohort Study.Semantic proximity Read ↗

FCGR2A single nucleotide polymorphism confers susceptibility to childhood-onset idiopathic nephrotic syndrome.Semantic proximity Read ↗

Is FCGR2A a susceptibility gene to systemic lupus erythematosus in Chinese?Semantic proximity Read ↗

Fc-gamma receptor polymorphisms differentially influence susceptibility to systemic lupus erythematosus and lupus nephritis.Semantic proximity Read ↗

Genetic markers in CYP2C19 and CYP2B6 for prediction of cyclophosphamide's 4-hydroxylation, efficacy and side effects in Chinese patients with systemic lupus erythematosus.Semantic proximity Read ↗

Association of FcγRIIA-R/H131 polymorphism and systemic lupus erythematosus lupus nephritis risk: A meta-analysis.Semantic proximity Read ↗

FcγRIIB Gene Polymorphisms Are Associated with Disease Risk and Clinical Manifestations of Systemic Lupus Erythematosus in Koreans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.